Saturn V Capital Management LP Diversified Active

Name: Saturn V Capital Management LP Q2 2026 13F Filing | 13F Explorer
Creator: Saturn V Capital Management LP
Published: 2026-08-14

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $697M (100.0% shares, 0.0% debt)

Holdings (23)

New Positions (3)

TRVI TREVI THERAPEUTICS INC 2.8%

Value $19.62M Shares 1,052,043 Est. Cost — Unrealized —

SGMT SAGIMET BIOSCIENCES INC 1.6%

Value $11.44M Shares 1,479,918 Est. Cost — Unrealized —

VIR VIR BIOTECHNOLOGY INC 1.1%

Value $7.853M Shares 770,643 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
TRVI	TREVI THERAPEUTICS INC	1,052,043	$19.62M	2.8%	—	—	COM	89532M101
SGMT	SAGIMET BIOSCIENCES INC	1,479,918	$11.44M	1.6%	—	—	COM SER A	786700104
VIR	VIR BIOTECHNOLOGY INC	770,643	$7.853M	1.1%	—	—	COM	92764N102

Increased Positions (12)

AMLX AMYLYX PHARMACEUTICALS INC 11.9%

Value $83.05M (+37.4%) Shares 4,624,101 (+6.3%) Est. Cost — Unrealized —

CADL CANDEL THERAPEUTICS INC 4.9%

Value $34.03M (+139.7%) Shares 3,303,686 (+14.1%) Est. Cost — Unrealized —

IMMX IMMIX BIOPHARMA INC 6.9%

Value $48.03M (+42.7%) Shares 4,658,429 (+26.1%) Est. Cost — Unrealized —

PHVS PHARVARIS N V 6.5%

Value $45.44M (+33.9%) Shares 1,314,122 (+9.4%) Est. Cost — Unrealized —

IRON DISC MEDICINE INC 5.5%

Value $38.38M (+33.4%) Shares 524,730 (+16.6%) Est. Cost — Unrealized —

ZURA ZURA BIO LTD 1.8%

Value $12.4M (+181.6%) Shares 2,101,119 (+184.0%) Est. Cost — Unrealized —

CELC CELCUITY INC 5.6%

Value $38.74M (+20.4%) Shares 370,318 (+31.4%) Est. Cost — Unrealized —

DYN DYNE THERAPEUTICS INC 3.4%

Value $23.49M (+34.0%) Shares 1,057,493 (+9.4%) Est. Cost — Unrealized —

XFOR X4 PHARMACEUTICALS INC 4.7%

Value $32.57M (+22.1%) Shares 6,973,343 (+8.0%) Est. Cost — Unrealized —

OCS OCULIS HOLDING AG 1.4%

Value $9.499M (-30.9%) Shares 684,880 (+32.5%) Est. Cost — Unrealized —

ANRO ALTO NEUROSCIENCE INC 0.7%

Value $4.825M (+141.2%) Shares 182,829 (+105.4%) Est. Cost — Unrealized —

PCVX VAXCYTE INC 7.1%

Value $49.58M (+3.5%) Shares 852,914 (+3.4%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
AMLX	AMYLYX PHARMACEUTICALS INC	4,624,101 (+6.3%)	$83.05M (+37.4%)	11.9%	—	—	COM	03237H101
CADL	CANDEL THERAPEUTICS INC	3,303,686 (+14.1%)	$34.03M (+139.7%)	4.9%	—	—	COM	137404109
IMMX	IMMIX BIOPHARMA INC	4,658,429 (+26.1%)	$48.03M (+42.7%)	6.9%	—	—	COM	45258H106
PHVS	PHARVARIS N V	1,314,122 (+9.4%)	$45.44M (+33.9%)	6.5%	—	—	COM	N69605108
IRON	DISC MEDICINE INC	524,730 (+16.6%)	$38.38M (+33.4%)	5.5%	—	—	COM	254604101
ZURA	ZURA BIO LTD	2,101,119 (+184.0%)	$12.4M (+181.6%)	1.8%	—	—	CLASS A ORD SHS	G9TY5A101
CELC	CELCUITY INC	370,318 (+31.4%)	$38.74M (+20.4%)	5.6%	—	—	COM	15102K100
DYN	DYNE THERAPEUTICS INC	1,057,493 (+9.4%)	$23.49M (+34.0%)	3.4%	—	—	COM	26818M108
XFOR	X4 PHARMACEUTICALS INC	6,973,343 (+8.0%)	$32.57M (+22.1%)	4.7%	—	—	COM NEW	98420X202
OCS	OCULIS HOLDING AG	684,880 (+32.5%)	$9.499M (-30.9%)	1.4%	—	—	ORDINARY SHARES	H5870P102
ANRO	ALTO NEUROSCIENCE INC	182,829 (+105.4%)	$4.825M (+141.2%)	0.7%	—	—	COM SHS	02157Q109
PCVX	VAXCYTE INC	852,914 (+3.4%)	$49.58M (+3.5%)	7.1%	—	—	COM	92243G108

Exited Positions (1)

COGT COGENT BIOSCIENCES INC 3.5%

Value $24.12M Shares 626,635 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
COGT	COGENT BIOSCIENCES INC	626,635	$24.12M	3.5%	—	—	—	19240Q201

Decreased Positions (6)

ALMS ALUMIS INC 11.8%

Value $82.04M (+16.3%) Shares 2,915,443 (-9.0%) Est. Cost — Unrealized —

MNPR MONOPAR THERAPEUTICS INC 4.1%

Value $28.89M (+52.5%) Shares 311,976 (-9.7%) Est. Cost — Unrealized —

ABVX ABIVAX SA 9.9%

Value $69.14M (+14.4%) Shares 518,865 (-4.4%) Est. Cost — Unrealized —

JAZZ JAZZ PHARMACEUTICALS PLC 5.6%

Value $38.78M (+25.9%) Shares 160,938 (-1.2%) Est. Cost — Unrealized —

OVID OVID THERAPEUTICS INC 0.3%

Value $1.784M (-80.7%) Shares 663,060 (-84.1%) Est. Cost — Unrealized —

IVVD INVIVYD INC 1.0%

Value $7.321M (-48.6%) Shares 8,392,288 (-23.4%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALMS	ALUMIS INC	2,915,443 (-9.0%)	$82.04M (+16.3%)	11.8%	—	—	COM	022307102
MNPR	MONOPAR THERAPEUTICS INC	311,976 (-9.7%)	$28.89M (+52.5%)	4.1%	—	—	COM NEW	61023L207
ABVX	ABIVAX SA	518,865 (-4.4%)	$69.14M (+14.4%)	9.9%	—	—	SPONSORED ADS	00370M103
JAZZ	JAZZ PHARMACEUTICALS PLC	160,938 (-1.2%)	$38.78M (+25.9%)	5.6%	—	—	SHS USD	G50871105
OVID	OVID THERAPEUTICS INC	663,060 (-84.1%)	$1.784M (-80.7%)	0.3%	—	—	COM	690469101
IVVD	INVIVYD INC	8,392,288 (-23.4%)	$7.321M (-48.6%)	1.0%	—	—	COM	00534A102

Unchanged Positions (2)

IKT INHIBIKASE THERAPEUTICS INC 1.1%

Value $7.854M Shares 3,869,056 Est. Cost — Unrealized —

MSLE SATELLOS BIOSCIENCE INC 0.4%

Value $2.721M Shares 350,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
IKT	INHIBIKASE THERAPEUTICS INC	3,869,056	$7.854M	1.1%	—	—	COM NEW	45719W205
MSLE	SATELLOS BIOSCIENCE INC	350,000	$2.721M	0.4%	—	—	COM	80401L803